<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" 
        xmlns:image="http://www.google.com/schemas/sitemap-image/1.1">
  <url>
    <loc>https://openbell.ai/</loc>
    <lastmod>2026-09-23T12:24:27.844Z</lastmod>
    <changefreq>hourly</changefreq>
    <priority>1.0</priority>
  </url>
  <url>
    <loc>https://openbell.ai/support</loc>
    <lastmod>2026-09-23T12:24:27.844Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
  </url>
  <url>
    <loc>https://openbell.ai/privacy</loc>
    <lastmod>2026-09-23T12:24:27.844Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://openbell.ai/terms</loc>
    <lastmod>2026-09-23T12:24:27.844Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://openbell.ai/feed.json</loc>
    <lastmod>2026-09-23T12:24:27.844Z</lastmod>
    <changefreq>hourly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://openbell.ai/news/COPX:1790166175846</loc>
    <lastmod>2026-09-23T12:22:55.846Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/09/23/Gold-Mining.jpg?width=250&amp;height=187</image:loc>
      <image:title>Canada Just Triggered a Mining Capex Rush: 2 Stocks Analysts Love Right Now</image:title>
      <image:caption>Canada&#39;s Prime Minister Mark Carney announced the &#39;Productivity Mega Deduction&#39; at the Canada Investment Summit, reducing the marginal effective tax rate on new business investments from approximately 13% to 6.4%, the lowest among major economies. This policy is expected to stimulate a $1 trillion investment target and significantly benefit the mining sector, with analysts highlighting Barrick Mining Corporation and Equinox Gold Corp. as top stock picks. Barrick is projected to generate about $8 billion in free cash flow over the next year, while Equinox is expected to benefit from its recent acquisition of Orla Mining.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/PKG:1790166174813</loc>
    <lastmod>2026-09-23T12:22:54.813Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/PKG/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>JP Morgan Maintains Overweight on Packaging Corp of America, Raises Price Target to $320</image:title>
      <image:caption>JP Morgan analyst Detlef Winckelmann has maintained an Overweight rating on Packaging Corp of America (NYSE: PKG) and raised the price target from $312 to $320. This adjustment reflects a positive outlook for the company&#39;s stock performance.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/COPX:1790166157101</loc>
    <lastmod>2026-09-23T12:22:37.101Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/COPX/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Canada Just Triggered a Mining Capex Rush: 2 Stocks Analysts Love Right Now</image:title>
      <image:caption>Canada&#39;s Prime Minister Mark Carney announced significant tax reforms at the Canada Investment Summit, introducing the &#39;Productivity Mega Deduction&#39; which reduces the marginal effective tax rate on new business investments to 6.4%, the lowest among major economies. This change is expected to stimulate a $1 trillion investment supercycle, particularly benefiting the mining sector, where companies can now recover 25-30% of capital spending in tax savings. TD Cowen highlighted Barrick Mining Corporation and Equinox Gold Corp. as top stock picks, with Barrick projected to generate $8 billion in free cash flow over the next year and Equinox benefiting from a recent acquisition.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/IP:1790166050591</loc>
    <lastmod>2026-09-23T12:20:50.591Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/IP/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>JP Morgan Maintains Overweight on International Paper, Raises Price Target to $62</image:title>
      <image:caption>JP Morgan analyst Detlef Winckelmann has maintained an Overweight rating on International Paper (NYSE: IP) and raised the price target from $61 to $62. This adjustment reflects a positive outlook for the company in the market.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/TLX:1790165718803</loc>
    <lastmod>2026-09-23T12:15:18.803Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/TLX/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Wedbush Reiterates Outperform on Telix Pharmaceuticals, Maintains $22 Price Target</image:title>
      <image:caption>Wedbush analyst David Nierengarten has reiterated an &#39;Outperform&#39; rating on Telix Pharmaceuticals (NASDAQ: TLX) and maintains a price target of $22 for the stock. This endorsement reflects the analyst&#39;s positive outlook on the company&#39;s performance.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/INVA:1790165604084</loc>
    <lastmod>2026-09-23T12:13:24.084Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/INVA/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Oppenheimer Assumes Innoviva at Outperform, Announces Price Target of $35</image:title>
      <image:caption>Oppenheimer analyst Les Sulewski has initiated coverage of Innoviva (NASDAQ: INVA) with an &#39;Outperform&#39; rating. The firm has set a price target of $35 for the company&#39;s stock.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/IONS:1790165592793</loc>
    <lastmod>2026-09-23T12:13:12.793Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/09/23/Konskie--Poland---ApIonis-Pharmaceutical.jpg?width=250&amp;height=187</image:loc>
      <image:title>Ionis and Roche Advance First RNA-Targeted Therapy for Autoimmune Kidney Disease</image:title>
      <image:caption>Ionis Pharmaceuticals Inc. and Roche Holdings AG reported positive interim results from their Phase 3 IMAgINATION trial for the RNA-targeted therapy sefaxersen, aimed at treating primary IgA nephropathy (IgAN). The trial met its primary endpoint at 37 weeks, showing significant reductions in proteinuria, a key indicator of kidney damage. The study will continue for 105 weeks to assess long-term kidney function, and Ionis has received an upfront payment and will earn royalties under its licensing agreement with Roche. Ionis shares rose 2.71% to $46.99 in premarket trading.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/CMPX:1790165570081</loc>
    <lastmod>2026-09-23T12:12:50.081Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/CMPX/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Wedbush Downgrades Compass Therapeutics to Neutral, Lowers Price Target to $1</image:title>
      <image:caption>Wedbush analyst Robert Driscoll has downgraded Compass Therapeutics (NASDAQ: CMPX) from Outperform to Neutral. The price target for the stock has been reduced significantly from $5 to $1.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/VNDA:1790165519879</loc>
    <lastmod>2026-09-23T12:11:59.879Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/VNDA/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Oppenheimer Initiates Coverage On Vanda Pharmaceuticals with Outperform Rating, Announces Price Target of $10</image:title>
      <image:caption>Oppenheimer analyst Les Sulewski has initiated coverage on Vanda Pharmaceuticals (NASDAQ: VNDA) with an Outperform rating. The analyst has set a price target of $10 for the company&#39;s stock.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/INFQ:1790165477168</loc>
    <lastmod>2026-09-23T12:11:17.168Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/09/23/quantum-compute-two.jpg?width=250&amp;height=187</image:loc>
      <image:title>Why Is Infleqtion Stock Surging on Wednesday?</image:title>
      <image:caption>Infleqtion Inc (NYSE: INFQ) stock surged 6.26% to $14.94 during premarket trading on Wednesday, driven by a sector-wide rally following a significant quantum computing breakthrough by IonQ, Inc (NYSE: IONQ). IonQ announced the successful development of the industry&#39;s first end-to-end, real-time quantum error correction decoder, which enhances the functionality of quantum systems. INFQ is currently trading above its key moving averages, indicating a bullish trend, with resistance at $16.50 and support at $12.50.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/AMRX:1790165433029</loc>
    <lastmod>2026-09-23T12:10:33.029Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/AMRX/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Oppenheimer Initiates Coverage On Amneal Pharmaceuticals with Outperform Rating, Announces Price Target of $27</image:title>
      <image:caption>Oppenheimer analyst Les Sulewski has initiated coverage on Amneal Pharmaceuticals (NASDAQ: AMRX) with an Outperform rating. The firm has set a price target of $27 for the company&#39;s stock.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/TEVA:1790165339794</loc>
    <lastmod>2026-09-23T12:08:59.794Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/TEVA/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Oppenheimer Initiates Coverage On Teva Pharmaceutical Indus with Outperform Rating, Announces Price Target of $50</image:title>
      <image:caption>Oppenheimer analyst Les Sulewski has initiated coverage on Teva Pharmaceutical Industries (NYSE: TEVA) with an Outperform rating. The firm has set a price target of $50 for the stock.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/MYSE:1790165292075</loc>
    <lastmod>2026-09-23T12:08:12.075Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/MYSE/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Myseum.AI Intends To Apply To Tokenize Its Nasdaq-Listed Common Stock On Blockchain Through Qualified Digital-Asset Platforms</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/DVLT:1790165241332</loc>
    <lastmod>2026-09-23T12:07:21.332Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/DVLT/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Datavault AI Announces Up To $50M Rights Offering Of Units At $0.20/Unit, Each Unit Bundle Of One Share Plus Rights To Buy Two More At $0.25 and $0.30/Share</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/LXEH:1790165197562</loc>
    <lastmod>2026-09-23T12:06:37.562Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2025/11/06/movers_4.jpg?width=250&amp;height=187</image:loc>
      <image:title>11 Consumer Discretionary Stocks Moving In Wednesday&amp;#39;s Pre-Market Session</image:title>
      <image:caption>In Wednesday&#39;s pre-market session, Lixiang Education Holding (NASDAQ: LXEH) shares increased by 18.2% to $1.62, with a market cap of $2.6 million. Wah Fu Education Group (NASDAQ: WAFU) stock rose 12.23% to $1.56, while E-Home Household Service (NASDAQ: EJH) saw a 9.32% increase to $1.29. Conversely, BrilliA (AMEX: BRIA) experienced a significant decline of 20.7% to $1.11, and SunCar Tech Group (NASDAQ: SDA) shares fell 15.76% to $0.41 following their Q2 earnings report.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/IMCC:1790165197375</loc>
    <lastmod>2026-09-23T12:06:37.375Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2025/11/06/movers_2.jpg?width=250&amp;height=187</image:loc>
      <image:title>12 Health Care Stocks Moving In Wednesday&amp;#39;s Pre-Market Session</image:title>
      <image:caption>In Wednesday&#39;s pre-market session, IM Cannabis (NASDAQ: IMCC) saw a significant increase of 56.3%, reaching $6.47, with a market cap of $2.5 million. Other notable gainers included Vistagen Therapeutics (NASDAQ: VTGN), which rose 55.92% to $0.39, and Decoy Therapeutics (NASDAQ: DCOY), which increased 36.45% to $4.23. Conversely, Jaguar Health (NASDAQ: JAGX) experienced a sharp decline of 47.9%, dropping to $17.95, while Henry Schein (NASDAQ: HSIC) fell 14.11% to $75.1.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/TSX:EDR:1790165196665</loc>
    <lastmod>2026-09-23T12:06:36.665Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/TSX:EDR/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>CIBC Downgrades Endeavour Silver to Neutral, Lowers Price Target to C$20</image:title>
      <image:caption>CIBC analyst Cosmos Chiu has downgraded Endeavour Silver (TSX: EDR) from Outperformer to Neutral. The price target for the stock has been reduced from C$25 to C$20.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/IPDN:1790165196051</loc>
    <lastmod>2026-09-23T12:06:36.051Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2025/11/06/movers_2.jpg?width=250&amp;height=187</image:loc>
      <image:title>12 Industrials Stocks Moving In Wednesday&amp;#39;s Pre-Market Session</image:title>
      <image:caption>In Wednesday&#39;s pre-market session, Professional Diversity (NASDAQ: IPDN) saw a significant increase of 76.9%, reaching $6.9, with a market cap of $2.5 million. Other notable gainers included Capstone Hldgs (NASDAQ: CAPS), which rose 22.46% to $0.22, and Worthington Enterprises (NYSE: WOR), which increased by 16.18% to $68.48 following its Q1 earnings release. Conversely, Zeo Energy (NASDAQ: ZEO) experienced a decline of 22.1%, falling to $0.38, while Rain Enhancement (NASDAQ: RAIN) dropped 15.94% to $0.86.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/IONQ:1790165195828</loc>
    <lastmod>2026-09-23T12:06:35.828Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2025/11/06/movers_3.jpg?width=250&amp;height=187</image:loc>
      <image:title>12 Information Technology Stocks Moving In Wednesday&amp;#39;s Pre-Market Session</image:title>
      <image:caption>In Wednesday&#39;s pre-market session, Gen Digital Inc. saw a significant increase of 28.0% to $3.2, while IonQ&#39;s shares rose by 12.59% to $45.87, bringing its market value to $16.5 billion. Other notable gainers included Locafy (+8.97% to $2.67) and UTime (+7.9% to $11.88). Conversely, Lianhe Sowell Intl experienced a decline of 23.1% to $0.68, and Saverone 2014 fell by 16.08% to $2.35.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/SLB:1790165166246</loc>
    <lastmod>2026-09-23T12:06:06.246Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/SLB/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>SLB Awarded Contract By OQ Exploration &amp;amp; Production To Deliver Bisat-B Expansion Production Facility In Oman</image:title>
      <image:caption>SLB has secured a contract from OQ Exploration &amp; Production to develop the Bisat-B Expansion Production Facility in Oman, enhancing their long-standing partnership. The project will increase the facility&#39;s gross fluids handling capacity to 548,000 barrels per day and includes design, engineering, procurement, construction, and four years of operations and maintenance support. Completion is expected within 19 months, following the successful delivery of previous facilities in the Bisat Field.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/ADGM:1790165119457</loc>
    <lastmod>2026-09-23T12:05:19.457Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/ADGM/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Adagio Medical&amp;#39;s Board Completes Strategic Review And Has Initiated A Formal Process To Explore Alternatives To Maximize Shareholder Value; May Include Acquisition, Merger, Business Combination, Or Other Transaction</image:title>
      <image:caption>Adagio Medical&#39;s Board of Directors has completed a strategic review and initiated a formal process to explore alternatives aimed at maximizing shareholder value, which may include an acquisition, merger, or other transactions. The company is also implementing a workforce reduction to align its cost structure with prioritized programs. As of June 30, 2026, Adagio reported approximately $7.7 million in cash, cash equivalents, and investments in marketable securities.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/VTRS:1790165106696</loc>
    <lastmod>2026-09-23T12:05:06.696Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/VTRS/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Oppenheimer Initiates Coverage On Viatris with Outperform Rating, Announces Price Target of $25</image:title>
      <image:caption>Oppenheimer analyst Les Sulewski has initiated coverage on Viatris (NASDAQ: VTRS) with an Outperform rating. The firm has set a price target of $25 for the company&#39;s stock.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/MCD:1790165088686</loc>
    <lastmod>2026-09-23T12:04:48.686Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/MCD/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>McDonald&amp;#39;s Targets Operating Margin In Low-To-Mid 50% Range By 2030; Plans $8.5B In Franchisee Support Through 2036</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/RAIN:1790165056570</loc>
    <lastmod>2026-09-23T12:04:16.570Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/RAIN/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Rain Enhancement And Tensor Networks Enter Into Binding LOI For Business Combination</image:title>
      <image:caption>Rain Enhancement Technologies Holdco, Inc. (NASDAQ: RAIN) has entered into a binding letter of intent to combine with Tensor Networks, Inc., a developer of predictive AI technology focused on infrastructure security. The transaction is expected to close in the first quarter of 2027, with both companies continuing to operate as separate subsidiaries under RAIN. This move highlights the increasing importance of securing AI infrastructure, particularly as AI adoption grows in various sectors, including government and defense.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/IONQ:1790165007982</loc>
    <lastmod>2026-09-23T12:03:27.982Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/IONQ/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>IonQ Announces Superion 256 Quantum Computer To Be First Installed In 2027 At Nvidia&amp;#39;s Quantum Research Center</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/INNV:1790164987716</loc>
    <lastmod>2026-09-23T12:03:07.716Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/09/23/Section-Of-A-Financial-Newspaper-Titled-.jpg?width=250&amp;height=187</image:loc>
      <image:title>InnovAge, Voyager Technologies And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session</image:title>
      <image:caption>InnovAge Holding Corp (NASDAQ: INNV) experienced a significant decline of 9.4% in pre-market trading, dropping to $9.65, following the announcement of a secondary offering of 10 million shares priced at $9.25 each by selling stockholders. This offering involves investment funds affiliated with Apax Partners and Welsh, Carson, Anderson &amp; Stowe. Other stocks also moving lower include Voyager Technologies Inc (NASDAQ: VOYG), which fell 6% to $35.36 after announcing a $350 million offering of convertible senior notes.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/RZLV:1790164964703</loc>
    <lastmod>2026-09-23T12:02:44.703Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/RZLV/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Rezolve Ai Announces Cost Reduction Program Targeting $60M In Annualized Savings; Targets Positive Adjusted EBITDA Exiting H1 2027</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/TWG:1790164959643</loc>
    <lastmod>2026-09-23T12:02:39.643Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/TWG/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Top Wealth Group Issues FY26 Net Profit Guidance For An Increase Of No Less Than 100% YoY</image:title>
      <image:caption>Top Wealth Group (TWG) has issued guidance for FY26, anticipating a net profit increase of no less than 100% year-over-year. Key drivers for this growth include extensive corporate marketing, successful sales of premium wine, and enhanced operational efficiency. The company is also focusing on strategic upward integration in its caviar business, aiming for balanced growth between its wine and caviar sectors in the future. The figures provided are preliminary estimates and may vary based on market conditions.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/VSAT:1790164931261</loc>
    <lastmod>2026-09-23T12:02:11.261Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/VSAT/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Viasat Announces $42M Initial Task Order Under Seven-Year, $307M Space Force Contract For Marine Corps Satellite Services</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/ANVS:1790164886007</loc>
    <lastmod>2026-09-23T12:01:26.007Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/ANVS/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Annovis Bio Announces Collaboration With Weave Bio On Buntanetap NDA; Expects Phase 3 Alzheimer&amp;#39;s Topline Data In March 2027</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/BKYI:1790164844784</loc>
    <lastmod>2026-09-23T12:00:44.784Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/BKYI/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>BIO-key Announces FIDO Alliance Full Certification For Passkey:YOU Passwordless Login Authenticator</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/CMND:1790164765226</loc>
    <lastmod>2026-09-23T11:59:25.226Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/CMND/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Clearmind Medicine Announces Three U.S. Patent Applications Covering Novel Proprietary Combinations Of LSD, Ketamine And Ibogaine With N-Acylethanolamines Such As Palmitoylethanolamide</image:title>
      <image:caption>Clearmind Medicine has announced three U.S. patent applications for novel combinations of LSD, ketamine, and ibogaine with N-acylethanolamines, targeting therapeutic uses for mental health disorders, pain, and substance use disorders. This development is part of an ongoing collaboration with NeuroThera Labs, which has led to a growing portfolio of patent applications. The company aims to create effective treatments at lower doses, potentially improving tolerability while maintaining therapeutic efficacy.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/MASK:1790164429782</loc>
    <lastmod>2026-09-23T11:53:49.782Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/MASK/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>3 E Network Technology Group&amp;#39;s Nordic Strategic Subsidiary, Aurora Core Technology Oy Enter Implementation, Execution Phase Of AI Data Center Project</image:title>
      <image:caption>3 E Network Technology Group Limited (NASDAQ: MASK) announced that its Nordic subsidiary, Aurora Core Technology Oy, has entered the implementation and execution phase of its AI data center project. This phase marks a shift from feasibility planning to localized construction preparation and procurement, leveraging the company&#39;s newly established multi-megawatt green energy architecture.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/BENF:1790164420421</loc>
    <lastmod>2026-09-23T11:53:40.421Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/BENF/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Beneficient shares are trading higher after the company announced a strategy to eliminate HCLP debt and Heppner Equity Interests.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/HCA:1790164155594</loc>
    <lastmod>2026-09-23T11:49:15.594Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/09/23/HCA-Healthcare.jpg?width=250&amp;height=187</image:loc>
      <image:title>This HCA Healthcare Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday</image:title>
      <image:caption>BMO Capital analyst Sean Dodge initiated coverage on HCA Healthcare Inc (NYSE:HCA) with an Outperform rating and set a price target of $495, while the stock closed at $438.12 on Tuesday. This marks a positive outlook for HCA as analysts begin to reassess their ratings in the healthcare sector.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/BBIO:1790164103341</loc>
    <lastmod>2026-09-23T11:48:23.341Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/BBIO/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>BridgeBio Says Acoramidis Associated With 34% Lower Risk Of Clinical Worsening vs. Tafamidis In Real-World Study</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/V:1790164023217</loc>
    <lastmod>2026-09-23T11:47:03.217Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/V/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Reap Partners With Visa To Roll Out Stable-Linked Visa Credit Program To More Than 100 Global Markets</image:title>
      <image:caption>Reap has partnered with Visa to launch stablecoin-linked Visa credit card programs in over 100 global markets, leveraging Reap&#39;s card issuance infrastructure. This collaboration aims to expand Reap&#39;s services beyond Asia and Latin America into the EMEA and African regions, ensuring compliance with local regulations.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/KLC:1790163963078</loc>
    <lastmod>2026-09-23T11:46:03.078Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/KLC/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Morgan Stanley Maintains Underweight on KinderCare Learning, Lowers Price Target to $2</image:title>
      <image:caption>Morgan Stanley analyst Toni Kaplan has maintained an Underweight rating on KinderCare Learning (NYSE: KLC) and has reduced the price target from $2.50 to $2. This adjustment reflects a cautious outlook on the company&#39;s performance.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/SDA:1790163954705</loc>
    <lastmod>2026-09-23T11:45:54.705Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/SDA/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>SunCar Technology Group shares are trading lower after the company reported worse-than-expected Q2 financial results.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/BOX:1790163832393</loc>
    <lastmod>2026-09-23T11:43:52.393Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/09/23/Claude-and-ChatGPT-are-leading-AI-powere.jpg?width=250&amp;height=187</image:loc>
      <image:title>OpenAI&amp;#39;s GPT-6 Just Got 50% Cheaper — Box CEO Says AI Agent Opportunity Could &amp;#39;Dramatically&amp;#39; Expand: &amp;#39;What an Insane Day&amp;#39;</image:title>
      <image:caption>Box Inc. CEO Aaron Levie highlighted a significant reduction in AI model costs, with OpenAI&#39;s GPT-6 Sol and Luna cutting token prices by 50%. He noted that this decline in costs could dramatically expand the use of AI agents across various tasks, potentially leading to broader adoption of AI in the economy. Levie emphasized that the rapid decrease in AI costs is unprecedented compared to other technologies, suggesting a trend that could enhance the efficiency of AI deployments.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/AIRO:1790163700593</loc>
    <lastmod>2026-09-23T11:41:40.593Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/AIRO/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>AIRO Group Announces Selection As One Of 17 Companies For Phase 2.5 Of Drone Dominance Program, Testing In October</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/IMCC:1790163673145</loc>
    <lastmod>2026-09-23T11:41:13.145Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/IMCC/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>IM Cannabis shares are trading higher after the company announced it will acquire a 51% stake in Space Defense Innovations.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/VEON:1790163585360</loc>
    <lastmod>2026-09-23T11:39:45.360Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/VEON/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>VEON Announces ~$200M Buyback Plan</image:title>
      <image:caption>VEON Ltd. has announced a share buyback program worth approximately $200 million, aimed at repurchasing 3.9% of its outstanding shares, totaling 72.5 million shares. The buyback is based on a closing price of $69.37 per American Depositary Share (ADS) as of September 22, 2026. The company has initiated the first phase of open market repurchases and plans to cancel all acquired shares to enhance capital allocation and long-term value.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/CBRL:1790163575300</loc>
    <lastmod>2026-09-23T11:39:35.300Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/CBRL/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Cracker Barrel Old Country Store shares are trading higher after the company reported better-than-expected Q4 financial results.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/URA:1790163477920</loc>
    <lastmod>2026-09-23T11:37:57.920Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/09/23/OLeary-Says-Success-Demands-Leaving-Comf.jpg?width=250&amp;height=187</image:loc>
      <image:title>Kevin O&amp;#39;Leary Explains Why His Big AI Bet is Uranium, Not Big Tech: &amp;#39;The Trade is Now the Energy Trade&amp;#39;</image:title>
      <image:caption>Kevin O&#39;Leary is shifting his investment strategy from AI technology stocks to energy infrastructure, particularly focusing on uranium and electricity production over the next 36 months. He emphasizes a &#39;picks and shovels&#39; approach, investing in energy stocks and nuclear power, citing small modular reactors as a key driver for future power generation. O&#39;Leary is concentrating his investments in regions with low electricity costs, such as Saskatchewan, Canada, and Nordic countries, and has purchased the iShares S&amp;P/TSX 60 Index ETF to gain exposure to these markets.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/TLSI:1790163454154</loc>
    <lastmod>2026-09-23T11:37:34.154Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/TLSI/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>TriSalus Life Sciences shares are trading higher after the company announced it received FDA 510(k) clearance for TriNav Advance</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/CLDX:1790163371781</loc>
    <lastmod>2026-09-23T11:36:11.781Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/CLDX/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Morgan Stanley Maintains Overweight on Celldex Therapeutics, Raises Price Target to $57</image:title>
      <image:caption>Morgan Stanley analyst Judah Frommer has maintained an Overweight rating on Celldex Therapeutics (NASDAQ: CLDX) and increased the price target from $50 to $57. This adjustment reflects a positive outlook for the company&#39;s performance in the market.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/VOYG:1790163325788</loc>
    <lastmod>2026-09-23T11:35:25.788Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/VOYG/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Voyager Technologies shares are trading lower after the company announced a $350 million offering of convertible senior notes.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/ARTL:1790163322264</loc>
    <lastmod>2026-09-23T11:35:22.264Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/ARTL/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Artelo Biosciences Files Provisional Patent Application For ART27.13 As Monotherapy And In Combination With GLP-1 Receptor Agonists</image:title>
      <image:caption>Artelo Biosciences has filed a provisional patent application for ART27.13, which has shown promising results in treating obesity. In a study, ART27.13 produced approximately 20% weight loss as a monotherapy and 40% when combined with semaglutide, with significant improvements in oral glucose tolerance and bone mineral density. The global GLP-1 market is projected to reach $200 billion by 2030, indicating potential market impact for Artelo&#39;s developments.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/IMVT:1790163311199</loc>
    <lastmod>2026-09-23T11:35:11.199Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/IMVT/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Immunovant shares are trading lower after the company announced topline results from Period 1 of its proof-of-concept trial evaluating IMVT-1402 did not achieve statistical significance on its primary endpoint.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
</urlset>